Skip to main content

Advertisement

SpringerLink
Log in

Thalidomide-induced symptomatic third-degree atrioventricular block

  • CLINICAL CORRESPONDENCE
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bernstein A (1997) Formed by thalidomide: mass torts as a false cure for toxic exposure. Columbia Law Rev 97:2153–2176

    Article  Google Scholar 

  2. Perri AJ, Hsu S (2003) A review of thalidomide’s history and current dermatological applications. Dermatol Online J 9:5

    PubMed  Google Scholar 

  3. D’Amato RJ, Loughnan MS, Flynn E, Folkmann J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Nat Acad Sci 91:4082–4485

    Article  PubMed  CAS  Google Scholar 

  4. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumour necrosis factor– alpha by enhancing mRNA degradation. J Exp Med 177:1675–1680

    Article  PubMed  CAS  Google Scholar 

  5. Sheskin J (1965) Thalidomide in the treatment of lepra reaction. Clin Pharmacol Ther 6:303–305

    PubMed  CAS  Google Scholar 

  6. Richardson P, Hideshima T, Anderson K. Thalidomide (2002) Emerging Role in Cancer Medicine. Annu Rev Med 53:629–657

    Article  PubMed  CAS  Google Scholar 

  7. Sleijfer S, Kruit W, Stoter HJ (2004) Thalidomid in solid tumours: the resurrection of an old drug European Journal of Cancer 40:2377–2382

    Article  PubMed  CAS  Google Scholar 

  8. Gullestadt L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Folling M, Hodt A, Skardal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Froland SS, Semb AG, Aukrust P (2005) Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double– blind, placebo–controlled study. Circulation 112:3408–3414

    Article  Google Scholar 

  9. Product information Pharmion Company, August 2004, version I

  10. Singhal S, Mehta J (2001) Thalidomide in cancer: potential uses and limitations. Bio Drugs 15:163–172

    CAS  Google Scholar 

  11. Teo SK, Evans MG, Brockman, Ehrhart J, Morgan M, Stirling DI, Thomas SD (2001) Safety profile of thalidomide after 53 weeks of oral administration on beagle dogs. Toxicological Sciences 59:160–168

    Article  PubMed  CAS  Google Scholar 

  12. Kaur A, Yu SS, Lee AJ, Chiao TB (2003) Thalidomide–induced sinus bradycardia. Ann Pharmacother 37:1040–1043

    Article  PubMed  Google Scholar 

  13. Fahdi IE, Gaddam V, Saucedo JF, Kishan CV, Vyas K, Deneke MG, Razek H, Thorn B, Bissett JK, Anaisse E, Barlogie B, Mehta JL (2004) Bradycardia during therapy for multiple myeloma with thalidomide. JACC 93:1052–1054

    CAS  Google Scholar 

  14. Schütt P, Ebeling P, Buttkereit U (2005) Thalidomide in combination with dexamethasone for pre–treated patients with multiple myeloma: serum level of soluble interleukin–2 receptor as a predictive factor for response rate and for survival. Ann Hematol 84:594–600

    Article  PubMed  Google Scholar 

  15. Palladini G, Perfetti V, Perlini S (2005) The combination of thalidomide and intermediate–dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis. Blood 105:2949–2951

    Article  PubMed  CAS  Google Scholar 

  16. Coutsouvelis J, Corallo CE (2004) Thalidomide– induced bradycardia and its management. Med J Aust 180:366–367

    PubMed  Google Scholar 

  17. Diggle GE (2001) Thalidomide: 40 years on. Int J Clin Pract 55:627–631

    PubMed  CAS  Google Scholar 

  18. Lemke B, Nowak B, Pfeiffer D (2005) Guidelines for heart pacemaker therapy. Z Kardiol 94:704–720

    Article  PubMed  CAS  Google Scholar 

  19. Schreieck J, Zrenner B, Dong J, Ndrepepa G, Schmitt C (2002) Dissimilar atrial rhythms: coexistence of reentrant atrial tachycardia, atrioventricular nodal reentrant tachycardia and interatrial conduction block. Z Kardiol 91:68–73

    Article  PubMed  CAS  Google Scholar 

  20. Betts TR (2003) Regional survey of temporary transvenous pacing procedures and complications. Postgrad Med J 79:463–465

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ludwig Maximilians University Munich Klinikum Großhadern, Department of Medicine I, 81366, Munich, Germany

    Martin Hinterseer MD, Alexander Becker MD, Stefan Kääb MD, Michael Näbauer MD & Gerhard Steinbeck MD

  2. Ludwig Maximilians University Munich, Klinikum Großhadern, Department of Medicine III, 81366, Munich, Germany

    Nicola Lang MD

Authors
  1. Martin Hinterseer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander Becker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan Kääb MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicola Lang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Näbauer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gerhard Steinbeck MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Hinterseer MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hinterseer, M., Becker, A., Kääb, S. et al. Thalidomide-induced symptomatic third-degree atrioventricular block. Clin Res Cardiol 95, 474–476 (2006). https://doi.org/10.1007/s00392-006-0401-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-006-0401-z

Keywords

Search

Navigation